Stock 2696 SHANGHAI HENLIUS BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Shanghai Henlius Biotech, Inc.

Equities

2696

CNE100003N76

Delayed Hong Kong S.E.
Other stock markets
 08:39:09 29/04/2024 BST 		5-day change 1st Jan Change
16.88 HKD +2.30% Intraday chart for Shanghai Henlius Biotech, Inc. +10.75% +21.58%
04-26 Shanghai Henlius Biotech's Cancer Drug Gets the Nod from US FDA MT
04-24 Shanghai Henlius Biotech Doses 1st Patient in Fibrosis Drug Clinical Study in China MT

Evolution of the average Target Price on Shanghai Henlius Biotech, Inc.

Price target over the last 5 years

History of analyst recommendation changes

583f6bcb7e38dc7f7cc10092ae64c3.3TbgctrY_xaTWebUpxefZk6PbN23jjWp7j-KBymWDHw.kV-HOZjhpmP7CLnl5kHUVH7KDY2D-EzipHv8S2LBIQiZeYQfipCNcqcQkQ~adf02ca8839249cfd404954f2351a4f1

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
15.27 CNY
Average target price
16.39 CNY
Spread / Average Target
+7.30%
High Price Target
23.05 CNY
Spread / Highest target
+50.91%
Low Price Target
8.352 CNY
Spread / Lowest Target
-45.32%

Consensus detail

Consensus revision (last 18 months)

Ratings for Shanghai Henlius Biotech, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 2696 Stock
  4. Consensus Shanghai Henlius Biotech, Inc.